Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux FilmArray Torch Wins FDA Clearance for Three Additional Syndromic Panels

NEW YORK (GenomeWeb) – BioMérieux today announced its molecular biology affiliate BioFire Diagnostics has received clearance from the US Food and Drug Administration for three additional molecular diagnostics panels on its high-throughput FilmArray Torch platform.

The Torch platform is a fully integrated, random and continuous access multiplex PCR system that provides up to six times more throughput compared to the firm's FilmArray system. It was cleared with the company's Respiratory Panel in February, and the current clearance now adds the Blood Culture Identification, Gastrointestinal, and Meningitis/Encephalitis panels, which were all previously cleared on the lower-throughput FilmArray system.

Both platforms run closed-system assays that integrate sample preparation, amplification, and detection, require two minutes of hands-on time, and have a total run time of about an hour.

BioMérieux also announced today that the FilmArray Torch has been CE marked.

"With the CE marking of the system, four FDA-cleared panels and more to come, the high-throughput FilmArray Torch is a major step forward in the global shift toward the syndromic diagnosis of infectious diseases and reinforces our leadership in this market," CEO of BioFire Diagnostics and VP Molecular Biology at BioMérieux Randy Rasmussen said in a statement.  

The number of FilmArray systems installed globally increased by more than 1,000 last year to reach about 2,500, and FilmArray revenues grew rapidly year over year, the firm further noted. The Torch system will be introduced in the coming days at the European Congress of Clinical Microbiology and Infectious Diseases being held in Amsterdam, The Netherlands.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.